Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Acs-Tens Treatment for Faecal Incontinence: a RCT With Sham-controls

6. februar 2021 oppdatert av: Tony Wing Chung Mak, Chinese University of Hong Kong

Transcutaneous Electric Nerve Stimulation on Acupoints (Acu-TENS) for the Treatment of Faecal Incontinence: a Prospective, Randomised, Sham-controlled Trial.

This study assess the effectiveness on AcuTENS on the treatment of faecal incontinence

Studieoversikt

Detaljert beskrivelse

Faecal incontinence (FI) is the involuntary loss of flatus, liquid or solid stool per rectum. Owing to the emotional stress and the psychosocial stigma surrounding this problem, it is under-reported by patients.

Conservative management of FI involves lifestyle, medical adjustments and pelvic floor sphincter training. If conservative treatment fails, surgical options such as sphincter repair, sacral nerve stimulation (SNM) and percutaneous tibial nerve stimulation (PTNS) can be reformed. SNM and PTNS involve application of nervous electrical stimulation (neuromodulation) with significant improvement of symptoms. The positions of electrical stimuli are also very similar to acupuncture sites (acupoints) used in Traditional Chinese Medicine for the treatment of faecal incontinence. However, disadvantage of these methods are; 1) they are invasive and may cause complications such as pain, infection and bleeding and; 2) the devices for each SNM device can be costly.

Transcutaneous Electrical Nerve Stimulation (TENS) is non-invasive, which is commonly used for the management of pain. It works via the application of electrical stimuli using adhesive gel pads. They are cheap to run and are widely accepted by patients. Hence application of TENS over acupoints (Acu-TENS) may provide a novel non-invasive treatment.

A randomised controlled trial will be carried out on patients with FI. Demographic data, past medical history, in particular any structural or neurological causes of FI, will be recorded. Ano-rectal manometry and endoanal ultrasound will be performed before and after treatment. Acu-TENS machine will be applied to standardised acupuncture points. Assessment of FI via Cleveland Clinic Florida Faecal Incontinence Score and Quality of life measurements via the validated questionnaires Short Form 36 (SF-36) and the Fecal Incontinence Quality of Life Scale (FIQL) (Chinese version) questionnaires will be carried out at baseline, and followup intervals.

Studietype

Intervensjonell

Registrering (Faktiske)

53

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Sha Tin, Hong Kong
        • Chinese University of Hong Kong

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 99 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Patients aged 18 years or above
  • Acupuncture naïve patients
  • Faecal incontinence with solid or liquid stool causing disruption of lifestyle
  • Psychological stability and suitability as determined by the investigator
  • Failed conservative or surgical treatment
  • Intact peripheral neurosensory nervous system as determined by clinical investigation
  • Able to read and write

Exclusion Criteria:

  • Major internal and/or external sphincter defect (>120 degrees of sphincter circumference)
  • Faecal impaction
  • Presence of full thickness rectal prolapse
  • Patients who have contact allergies to adhesive pads
  • Implanted pacemaker, defibrillator, cardiopathy
  • Pregnancy or intention to become pregnant
  • Neurogenic or congenital disorders resulting in faecal incontinence (e.g. Multiple Sclerosis, uncontrolled diabetes, Parkinson's disease, Spina Bifida)
  • Inflammatory bowel disease
  • Chronic diarrhoea uncontrolled by medication or diet
  • Previous rectal surgery (rectopexy or rectal resection)

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: AcuTENS
Patients treated with TENS over Acupuncture points for faecal incontinence
Stimulation of acupuncture points with TENS machine
Sham-komparator: Sham
Sham treatment arm with no electrical stimulations over acupuncture points
Stimulation of acupuncture points with TENS machine

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Effectiveness of AcuTENS as treatment for faecal incontinence compared with sham intervention
Tidsramme: post treatment 8 weeks and 6 months compared with baseline
Response to treatment is defined as 50% or greater change in Faecal incontinence Severity index score compared to sham
post treatment 8 weeks and 6 months compared with baseline

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Changes in the severity of faecal incontience
Tidsramme: post treatment 8 weeks and 6 months compared with baseline
Wexner score will be used the assess the severity of faecal incontinence
post treatment 8 weeks and 6 months compared with baseline
Episodes of faecal urgency per week
Tidsramme: post treatment 8 weeks and 6 months compared with baseline
the number of episodes of faecal urgency experienced by the patient per week
post treatment 8 weeks and 6 months compared with baseline
Reduction in the number of incontinence episode per week
Tidsramme: post treatment 8 weeks and 6 months compared with baseline
the number of episodes of faecal incontience experienced by the patient per week
post treatment 8 weeks and 6 months compared with baseline
Differences in Quality of Life score between two groups
Tidsramme: post treatment 8 weeks and 6 months compared with baseline
using the tradition chinese version of the faecal incontinence quality of life questionnaire (FIQL)
post treatment 8 weeks and 6 months compared with baseline

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Tony WC Mak, MD, FRCS, Chinese University of Hong Kong

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. august 2017

Primær fullføring (Faktiske)

30. oktober 2020

Studiet fullført (Faktiske)

31. desember 2020

Datoer for studieregistrering

Først innsendt

2. februar 2021

Først innsendt som oppfylte QC-kriteriene

6. februar 2021

Først lagt ut (Faktiske)

11. februar 2021

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

11. februar 2021

Siste oppdatering sendt inn som oppfylte QC-kriteriene

6. februar 2021

Sist bekreftet

1. februar 2021

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

3
Abonnere